1196475-05-4

Upstream product

• 59142-68-6 2-bromo-4-fluorobenzaldehyde 
• 7070-85-1 3-[1,3]dioxolan-2-yl-phenol 
• 100-83-4 meta-hydroxybenzaldehyde 
• 1196475-04-3 2-bromo-4-(3-[1,3]dioxolan-2-yl-phenoxy)-benzaldehyde 
• 73183-34-3 bis(pinacol)diborane 

Downstream Products

• 1426224-14-7 C₁₄H₁₁BO₄ 
• 1426224-18-1 C₁₈H₂₀BNO₄*ClH 
• 1196473-84-3 (1-hydroxy-6-(3-morpholin-4-ylmethyl-phenoxy)-1,3-dihydro-benzo[c][1,2]oxaborol-3-yl)-acetic acid hydrochloride salt 
• 1196475-02-1 4-[3-(3-carboxymethyl-1-hydroxy-1,3-dihydro-benzo[c][1,2]oxaborol-6-yloxy)-benzyl]-piperazine-1-carboxylic acid tert-butyl ester 
• 1196475-06-5 (6-(3-[1,3]dioxolan-2-yl-phenoxy)-1-hydroxy-1,3-dihydro-benzo[c][1,2]oxaborol-3-yl)-acetic acid ethyl ester 

Relevant academic research and scientific papers

Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent

A series of novel 6-(aminomethylphenoxy)benzoxaborole analogs was synthesized for the investigation of the structure-activity relationship of the inhibition of TNF-alpha, IL-1beta, and IL-6, from lipopolysaccharide stimulated peripheral blood mononuclear cells. Compounds 9d and 9e showed potent activity against all three cytokines with IC50 values between 33 and 83 nM. Chloro substituted analog 9e (AN3485) is considered to be a promising lead for novel anti-inflammatory agent with a favorable pharmacokinetic profile.

BORON-CONTAINING SMALL MOLECULES

This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.